Impact of early diagnosis on functional disability in rheumatoid arthritis
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background/Aims: To determine whether early diagnosis is beneficial for functional status of various disease durations in rheumatoid arthritis (RA) patients. Methods: A total of 4,540 RA patients were enrolled as part of the Korean Observational Study Network for Arthritis (KORONA). We defined early diagnosis as a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas patients with a longer lag time comprised the delayed diagnosis group. Demographic characteristics and outcomes were compared between early and delayed diagnosis groups. Logistic regression analyses were performed to identify the impact of early diagnosis on the development of functional disability in RA patients. Results: A total of 2,597 patients (57.2%) were included in the early diagnosis group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66, p < 0.01), and the proportion of patients with no functional disability (HAQ = 0) was higher in the early diagnosis group (22.9% vs. 20.0%, p = 0.02). In multivariable analyses, early diagnosis was independently associated with no functional disability (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.01 to 1.40). In a subgroup analysis according to disease duration, early diagnosis was associated with no functional disability in patients with disease duration < 5 years (OR, 1.37; 95% CI, 1.09 to 1.72) but not in patients with longer disease duration (for 5 to 10 years: OR, 1.07; 95% CI, 0.75 to 1.52; for ≥ 10 years: OR, 0.92; 95% CI, 0.65 to 1.28). Conclusions: Early diagnosis is associated with no functional disability, especially in patients with shorter disease duration.
Abstract
Background/Aims: To determine whether early diagnosis is beneficial for functional status of various disease durations in rheumatoid arthritis (RA) patients. Methods: A total of 4,540 RA patients were enrolled as part of the Korean Observational Study Network for Arthritis (KORONA). We defined early diagnosis as a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas patients with a longer lag time comprised the delayed diagnosis group. Demographic characteristics and outcomes were compared between early and delayed diagnosis groups. Logistic regression analyses were performed to identify the impact of early diagnosis on the development of functional disability in RA patients. Results: A total of 2,597 patients (57.2%) were included in the early diagnosis group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66, p < 0.01), and the proportion of patients with no functional disability (HAQ = 0) was higher in the early diagnosis group (22.9% vs. 20.0%, p = 0.02). In multivariable analyses, early diagnosis was independently associated with no functional disability (odds ratio [OR], 1.19; 95% confidence interval [CI], 1.01 to 1.40). In a subgroup analysis according to disease duration, early diagnosis was associated with no functional disability in patients with disease duration < 5 years (OR, 1.37; 95% CI, 1.09 to 1.72) but not in patients with longer disease duration (for 5 to 10 years: OR, 1.07; 95% CI, 0.75 to 1.52; for ≥ 10 years: OR, 0.92; 95% CI, 0.65 to 1.28). Conclusions: Early diagnosis is associated with no functional disability, especially in patients with shorter disease duration.
참고문헌 (24)
- Breedveld F., "The value of early intervention in RA: a window of opportunity", Clin Rheumatol, 30(Suppl 1), pp.S33~S39 (2011)
- Cush JJ., "Early rheumatoid arthritis: is there a window of opportunity?", J Rheumatol Suppl, 80, pp.1~7 (2007)
- Bosello S, "Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression", Ann Rheum Dis, 70, pp.1292~1295 (2011)
- Kyburz D, "The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: apopulation-based cohort study", Rheumatology (Oxford), 50, pp.1106~1110 (2011)
- Lukas C, "Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis)", Arthritis Rheum, 63, pp.1804~1811 (2011)
- Finckh A, "Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis", Arthritis Rheum, 55, pp.864~872 (2006)
- Mottonen T, "Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis", Arthritis Rheum, 46, pp.894~898 (2002)
- Gremese E, "Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study", Ann Rheum Dis, 72, pp.858~862 (2013)
- Lard LR, "Early versus delayed treatment in patients with recent-onset rheumatoid arthritis:comparison of two cohorts who received different treatment strategies", Am J Med, 111, pp.446~451 (2001)
- Nell VP, "Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis", Rheumatology (Oxford), 43, pp.906~914 (2004)
- Descalzo MA, "Effectiveness of a clinical practice intervention in early rheumatoid arthritis", Arthritis Care Res (Hoboken), 64, pp.321~330 (2012)
- Arnett FC, "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis", Arthritis Rheum, 31, pp.315~324 (1988)
- Sung YK, "Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea", Semin Arthritis Rheum, 41, pp.745~751 (2012)
- Bae SC, "Psychometric evaluation of a Korean Health Assessment Questionnaire for clinical research", J Rheumatol, 25, pp.1975~1979 (1998)
- Welsing PM, "The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis", Arthritis Rheum, 44, pp.2009~2017 (2001)
- Escalante A, "How much disability in rheumatoid arthritis is explained by rheumatoid arthritis?", Arthritis Rheum, 42, pp.1712~1721 (1999)
- Cho SK, "Do patients with elderly-onset rheumatoid arthritis have severe functional disability?", Semin Arthritis Rheum, 42, pp.23~31 (2012)
- Aletaha D, "2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.62, 2569~2581
- Wells GA, "Minimum important difference between patients with rheumatoid arthritis: the patient’s perspective", J Rheumatol, 20, pp.557~560 (1993)
- Redelmeier DA, "Assessing the clinical importance of symptomatic improvements: an illustration in rheumatology", Arch Intern Med, 153, pp.1337~1342 (1993)
- kosinski M, "Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis", Arthritis Rheum, 43, pp.1478~1487 (2000)
- Greenwood MC, "Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis?", Ann Rheum Dis, 60, pp.344~348 (2001)
- Pope JE, "The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials", J Rheumatol, 36, pp.254~259 (2009)
- Sokka T, "Functional disability in rheumatoid arthritis patients compared with a community population in Finland", Arthritis Rheum, 48, pp.59~63 (2003)